Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391430 · ClinicalTrials.gov registry record · Phase 4
Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
A Phase 4 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT00391430 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 39 participants.
The verdict
NCT00391430, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study will evaluate which parts of the brain are affected by treatment with behavioral therapy versus medication therapy in people with post-traumatic stress disorder.
Interventions
- DRUG Sertraline
- BEHAVIORAL Cognitive behavioral therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00391430
The ClinicalTrials.gov registry entry for NCT00391430 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sertraline is the first listed.
NCT00391430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00391430 about?
NCT00391430 is a clinical study titled "Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder". This study will evaluate which parts of the brain are affected by treatment with behavioral therapy versus medication therapy in people with post-traumatic stress disorder.
What is the current status of trial NCT00391430?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2005-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00391430?
The interventions under investigation include: Sertraline (DRUG), Cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00391430?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.